Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation
Sponsor: South Valley University
Summary
Posterior urethral valve is the main cause of bladder outlet obstruction in male infants and the most common cause of obstructive uropathy leading to chronic renal failure and end-stage renal disease in children.The incidence of posterior urethral valve is approximately 1:7,000-8,000 live births.
Official title: Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation: A Comparative Prospective Randomized Study
Key Details
Gender
MALE
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2025-01-01
Completion Date
2025-12-30
Last Updated
2026-06-25
Healthy Volunteers
No
Conditions
Interventions
Mirabegron
To assess the efficacy and the safety of Mirabegron and Oxybutynin drugs after posterior urethral valve ablation regarding: the Effect on upper and lower urinary tract and Febrile UTI recurrence.
Locations (1)
Qina University hospital, South Valley University Hospital
Qina, South Valley, Egypt